ROBERT LANGER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT LANGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT LANGER. ROBERT LANGER is a Director in Ocata Therapeutics, Inc. ($ACTC) and a Director in Lyra Therapeutics, Inc. ($LYRA) and a Director in BIND Therapeutics, Inc ($BIND) and a Director in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Moderna, Inc. ($MRNA) and a Director in Frequency Therapeutics, Inc. ($FREQ) and a Director in Rubius Therapeutics, Inc. ($RUBY) and a Director in Seer, Inc. ($SEER).
Companies in which ROBERT LANGER is an Insider
DNIB UNWIND, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT LANGER: Director
Holdings: 738,424 shares
Latest Transaction: Aug 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Frequency Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT LANGER: Director
Holdings: 214,326 shares
Latest Transaction: Nov 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kala Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT LANGER: Director
Holdings: 0 shares
Latest Transaction: Jun 15 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lyra Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT LANGER: Director
Holdings: 15,167 shares
Latest Transaction: May 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Moderna, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT LANGER: Director
Holdings: 11,466,961 shares
Latest Transaction: Apr 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT LANGER: Director
Holdings: 0 shares
Latest Transaction: Feb 11 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rubius Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT LANGER: Director
Holdings: 7,500 shares
Latest Transaction: Oct 17 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seer, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ROBERT LANGER: Director
Holdings: 0 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT LANGER
Sentiment: All, BIND, FREQ, KALA, LYRA, MRNA, ACTC, RUBY, SEER
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
| Apr 30 2021 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
| Dec 11 2020 | SEER | Seer, Inc. | LANGER ROBERT | Director | Option Exercise | A | 19.00 | 18,691 | 355,129 | 18,691 | |
| Nov 19 2020 | FREQ | Frequency Therapeu ... | LANGER ROBERT | Director | Gift | G | 0.00 | 56,912 | 0 | 214,326 | 271.2 K to 214.3 K (-20.98 %) |
| Jun 12 2020 | FREQ | Frequency Therapeu ... | LANGER ROBERT | Director | Option Exercise | A | 18.63 | 14,846 | 276,581 | 14,846 | |
| May 06 2020 | LYRA | Lyra Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | C | 0.00 | 23,057 | 0 | 0 | |
| May 06 2020 | LYRA | Lyra Therapeutics, ... | LANGER ROBERT | Director | Buy | C | 0.00 | 668 | 0 | 15,167 | 14.5 K to 15.2 K (+4.61 %) |